V
V-beam laser, for burn reconstruction 1598
V/Q scans See Ventilation/perfusion scans
VT (tidal volume) 221 223
V2 vasopressin receptor antagonist, for hyponatremia 870
v wave 314
VA See Visual acuity
vacA gene, in Helicobacter pylori gastritis 584
Vaccine bacillus Calmette-Gu rin (BCG) 263
tuberculin skin test affected by 258 259 263
Vaccine-derived poliomyelitis 1367
Vaccine-preventable viral infections 1362–1369
Vaccines See specific type and Immunization
Vaccinia 110–111 1388
in atopic dermatitis patients 96 111 1388
smallpox vaccination and 111 1312 1313 1388
Vaccinia gangrenosum 111
Vaccinia immune globulin 111 1313
P.1879
Vaccinia necrosum 1313
Vacuum constriction device, for erectile dysfunction 951–952 1224–1225
VAD regimen, for myeloma 516
Vagal nerve stimulation
for depression 1074
for seizures 985
Vagifem See Estradiol vaginal tablets
Vaginal atrophy See Atrophic vaginitis
Vaginal bleeding See also Dysfunctional uterine bleeding; Menstruation
abnormal premenopausal 728–730
cervical polyps causing 728 733
in polycystic ovary syndrome 746
in cervical cancer 737
in ectopic pregnancy 780
in endometrial carcinoma 738
leiomyomas causing 737 738
postmenopausal 730
during pregnancy
gestational trophoblastic disease and 773–774
third-trimester 774–775
Vaginal cancer
DES exposure and 733
Pap smear in screening for 16
Vaginal delivery See also Labor and delivery
for cardiac patient 417
Vaginal dryness See Atrophic vaginitis
Vaginal estrogen 1186–1187
Vaginal hernias (genital prolapse) 741
Vaginal intraepithelial neoplasia, DES exposure and 733
Vaginal pessary See Pessary
Vaginal ring
for atrophic vaginitis 748 761 1186–1187
contraceptive 754
Vaginal ultrasound See Ultrasonography
Vaginal warts 732 733
Vaginismus 747 747–748 1053 1054
Vaginitis/vulvovaginitis 731–733 747
atrophic See Atrophic vaginitis
candidal 121 732 1536
in diabetes 1198 1198 1226
in HIV infection/AIDS 1329 1336 1347
gonococcal 1432
painful intercourse caused by 747
Trichomonas vaginalis causing 732
Vaginosis, bacterial 732
rape/sexual assault in transmission of 1297
Valacyclovir 1353 1587
cost of 1563
for herpes simplex infections 109 1336 1351–1353 1353 1587
for herpes zoster 110 1336 1353 1587
prophylactic/suppressive 109 1587
for varicella 1353 1357
Valdecoxib 587
withdrawal of from market 74
Valganciclovir, for cytomegalovirus infection treatment/prophylaxis 168 1290 1335 1353 1361 1588
Valium See Diazepam
Valproic acid/valproate 984 985
for bipolar disease/mania 1077
lithium interactions and 1077
monitoring concentrations of 1077 1735
overdose/toxicity of 1615 1619
hemodialysis for 1613 1619
for seizures 983 984 985
Valsalva maneuver
heart murmurs affected by 329
for paroxysmal supraventricular tachycardia 373
Valsartan
for cardiac failure 392
for hypertension 433 435
with hydrochlorothiazide 435
for myocardial infarction 360
Valtrex See Valacyclovir
Valve replacement
anticoagulation after 338–339
endocarditis and 1419
pregnancy and 339
for aortic regurgitation 335–336
for aortic stenosis 333–334
choice and management of prosthetic valves for 338–339
for endocarditis 338 1419
endocarditis after 1408 1415
in Marfan's syndrome 1708
for mitral stenosis 330
percutaneous approaches to 338
for pulmonary stenosis 319
for tricuspid regurgitation 337
for tricuspid stenosis 336
Valves
cardiac See Prosthetic heart valves; Valve replacement; Valvular heart disease
venous, incompetence of
chronic venous insufficiency and 473
varicose veins and 468–469
Valvular heart disease 325–339 326–328
cardiac failure and 387
endocarditis and 1415
fenfluramine/dexfenfluramine causing 1269
in Marfan's syndrome 414 1707 1708
pregnancy and 416 778
preoperative evaluation/management of patient with 40
Q fever endocarditis and 1397 1398
rheumatic fever/rheumatic heart disease and 325 336 405 406
Valvular papillary fibroelastoma 413
Valvular rupture, traumatic 414
Valvuloplasty 338
for aortic stenosis 334
for mitral stenosis 329
during pregnancy 330 416
for pulmonary stenosis 319
Vanceril See Beclomethasone
Vancocin See Vancomycin
Vancomycin 1578
for anthrax prophylaxis/treatment 1412
for antibiotic-associated colitis 620 1578
cost of 1561 1563
for endocarditis prophylaxis 1417 1418 1418 1419 1578
monitoring concentrations of 1735
red man syndrome caused by 795 1578
resistance to 1407 1578
therapy adjustments in renal or hepatic failure and 1559 1578
Vanillylmandelic acid, urinary
laboratory reference range for 1743
in pheochromocytoma 1175
Vantin See Cefpodoxime proxetil
Vaqta See Hepatitis A vaccine
Vardenafil 952 1054 1224
Variant (Prinzmetal's) angina 347
Varicella (chickenpox) 1354–1358 1355
immunization against 1305–1306 1307–1309 1311–1312 1357
during pregnancy 780–781 1356
reactivation of 1354
Varicella-zoster immune globulin 1357
for newborn 781 1356
during pregnancy 781
Varicella-zoster virus 1354
Bell's palsy caused by 1356
infection with during pregnancy 780–781 1356
reactivation of 1354
Varicella-zoster virus vaccine 1305–1306 1307–1309 1311–1312 1357
HIV infection/AIDS and 1308 1357
pregnancy and 1308 1312 1357
Varicocele 933
in infertility 749 953 954
Varicose veins (varicosities/varices) 468–470
esophageal See Esophageal varices
gastrointestinal bleeding from 551–552
noncirrhotic portal hypertension causing 680
leg ulcers and 141 469
venous insufficiency/stasis and 469 473
Variegate porphyria 1024–1025
Variola (smallpox) 110–111 1356 1388
bioterrorism and 111 1312 1388
Variola (smallpox) vaccination 4–5 111 1312–1313 1388
atopic dermatitis/eczema and 96 111 1313 1388
Varus ankle sprains 826
Vas deferens, obstruction of, in infertility 954
Vasa previa, third trimester bleeding caused by 774
Vascular access See also Arterial lines; Intravenous lines
in burn care 1596–1597
Vascular (multi-infarct) dementia 1092
hypertension and 425
Vascular disorders (vascular occlusion/anomalies) 446–475
arterial aneurysms 446–452
arteriopathies 462–464
atherosclerotic 453–462
homocysteine/hyperhomocysteinemia and 10–11 341 1706–1707
in diabetes mellitus 1225
aspirin in prevention of 1205 1225
foot ulcers/gangrene and 1223 1225
glycemic control and 1202 1203 1203–1205 1225
gastrointestinal bleeding and 552 554–555
headache and 32 978
hepatic vein (Budd-Chiari syndrome) 678–680
hypotension/shock and 477–480 478
impotence/erectile dysfunction and 453 454 951 952 1101
during pregnancy 417
seizures caused by 980
in sickle cell syndromes 493
of spinal cord 999
vasomotor 464–468
venous 468–475
vertigo caused by 194
Vascular ectasias (angiodysplasias), gastrointestinal bleeding in 552 554–555
Vascular endothelial growth factor (VEGF), in tumor angiogenesis, cancer treatment and 1667 1699
Vascular loops, vertigo caused by 194
Vascular reconstruction See Bypass grafting
P.1880
Vascular surgery, antibiotic prophylaxis for 47
Vasculitis 464 844–851 844 845
allergic, drugs causing 147 793
brain and spinal cord involvement and (primary angiitis of central nervous system) 851
cancer-related 863
pulmonary 292–293
retinal 162
in rheumatoid arthritis 828
in systemic lupus erythematosus 835
urticarial 121
Vasectomy 758
Vasoactive drug therapy
in erectile dysfunction 952 1224
diagnosis and 951
for shock 479–480
Vasoactive intestinal polypeptide (VIP), tumors secreting 1178 1191 1692
Vasodilator therapy
for aortic regurgitation 335
for cardiac failure 393–394
infarct-associated 363
for dementia 1093
for hypertension 437 438
for pulmonary hypertension 292
for Raynaud's disease/phenomenon 465
Vasomotor disorders 464–468
in menopause 761 761–762 1185
syncope (vasovagal/neurocardiogenic syncope) 313 384
Vaso-occlusive episodes, in sickle cell syndromes 493 494
Vasopressin See also Desmopressin
in cardiac failure 386
in gastrointestinal bleeding 554 556
for shock 479–480
Vasopressin challenge test, in diabetes insipidus 1109
Vasopressin V2 receptor antagonist, for hyponatremia 870
Vasopressinase, diabetes insipidus caused by 1108
Vasospasm See also Vasomotor disorders
in acrocyanosis 466
coronary 347
intracranial aneurysm and 996
in livedo reticularis 466
in Raynaud's disease/phenomenon 464 465
Vasotec See Enalapril; Enalaprilat
Vasovagal (vasomotor/neurocardiogenic) syncope 313 384
VATS See Video-assisted thoracoscopic surgery
VC (vital capacity) 223
forced (FVC) 223
in asthma 227
in COPD 238
ratio of to forced expiratory volume in one second 222 223
in asthma 227
in COPD 238
vCJD See New variant Creutzfeldt-Jakob disease
VDRL test 1444–1445 1444
in anorectal infection 645
antiphospholipid antibody/lupus anticoagulant affecting 532
on cerebrospinal fluid (CSF-VDRL) 1446
in HIV infection/AIDS 1332
in HIV infection/AIDS 1332 1452
in newborn 1453
for rape victim 759
Vegetarians/vegans, dietary vitamin B12 deficiency in 487
Vegetative state, persistent 1019
VEGF See Vascular endothelial growth factor
Veins
deep, thrombophlebitis involving 470–472
disorders of 468–475
superficial, thrombophlebitis involving 472–473
varicose See Varicose veins
Velcade See Bortezomib
Velosulin See also Insulin therapy
Vena cava filters/interruption, for pulmonary embolism 289
Venereal Disease Research Laboratory test See VDRL test
Venereal (genital) warts 127 128
anorectal involvement and 128 645–646
imiquimod for removal of 128 646
podophyllum resin for removal of 128 646 733
vaginal/vulvar 732 733
Venereal infections See Sexually transmitted diseases
Venezuelan equine encephalitis 1371–1373
Venlafaxine 1070 1072
for anxiety 1046
for depression 1070 1072
overdose/toxicity of, seizures/serotonin syndrome caused by 1637
withdrawal from 1070
Venography
in deep venous thrombosis/pulmonary embolism 283 471
renal 900
Venom immunotherapy 792
Venomous snake bites 1611 1635–1636
Venomous stings 136 1636
anaphylaxis caused by 791
immunotherapy for 792
Veno-occlusive disease
hepatic (Budd-Chiari syndrome) 678–680
pulmonary 290–291
Venous access, in burn care 1596
Venous blood gases, in acid-base disorders 885
Venous catheterization, nosocomial infection and 1292
Venous insufficiency/stasis 473–475
deep venous thrombosis/thrombophlebitis and 24–26 25 281 470 471 473
pulmonary embolism and 280–281 283
leg ulcers and 141–142 474
lower extremity edema and 24–26 25 473
varicose veins and 469 473
Venous pressure
central See Central venous pressure
elevated
chronic venous insufficiency and 473
in constrictive pericarditis 409
Venous pulsations, in heart disease 314
Venous sinus thrombosis
in cancer 1005
in pseudotumor cerebri 1005
Venous stasis See Venous insufficiency/stasis
Venous thrombosis
in antiphospholipid antibody syndrome 837–838
in burn injury 1598
cancer-associated 531
of deep veins 470–472
detection of 281–284 282 285
in essential thrombocytosis 502
estrogen replacement therapy and 1188
in homocystinuria 1706
intracranial 998
oral contraceptive use and 470 752–753
prevention of 284 286 287 471–472
pulmonary embolism and 280–281 283
of superficial veins 472–473
treatment of 284–289 288
in Wegener's granulomatosis 848
Venous valves, incompetence of
chronic venous insufficiency and 473
varicose veins and 468–469
Ventilation
disorders of control of 304–306
mechanical See Mechanical ventilation
Ventilation/perfusion scans
in COPD 239
in pulmonary embolism 282–283
in pulmonary heart disease 412
in pulmonary hypertension 291
Ventilator-associated pneumonia 253 254 308
Ventolin See Albuterol
Ventricular aneurysm, myocardial infarction and 364
Ventricular arrhythmias 379–382
atrial fibrillation and 375
in cardiac failure 395
in cardiomyopathy 403
differentiation of from aberrantly conducted supraventricular beats 372
in myocardial infarction 356 362
prevention of 361
premature beats (extrasystoles) 379
in myocardial infarction 361
tachycardia 379–380
driving recommendations and 385
in myocardial infarction 362
in poisoning/drug overdose 1609
syncope caused by 313
Ventricular assist devices, for heart failure 396
Ventricular cysts, in cysticercosis 1511 1512
Ventricular dysfunction/failure See Congestive heart (cardiac) failure; Left heart failure
Ventricular fibrillation 380–381
electric shock causing 1599
in myocardial infarction 356 362
prevention of 361
sudden death caused by 356 380–381
Ventricular gallop See Heart sounds; Third heart sound
Ventricular reduction surgery, for heart failure 396
Ventricular septal defect 322–323
Verapamil See also Calcium channel blocking drugs
for arrhythmias 370
atrial fibrillation 376
paroxysmal supraventricular tachycardia 373
for hypertension 435 436
for migraine prophylaxis 976
overdose/toxicity of 1621
Verbal utterance See also Speech
in schizophrenia/psychotic disorders 1057
Verbigeration, in schizophrenia/psychotic disorders 1057
Verelan See Verapamil
Vernal keratoconjunctivitis 157
Verner-Morrison syndrome 1178 1191
Verrucae See Warts
Versed See Midazolam
P.1881
Vertebral artery occlusion, stroke caused by 993
Vertebral fracture
back pain caused by 817
falls in elderly and 61
in Paget's disease 1162
Vertebral osteomyelitis
back pain and 817
epidural abscess and 859 1406
Vertebrobasilar insufficiency/obstruction
stroke caused by 991–993 992
transient ischemic attacks caused by 456 989
vertigo caused by 194
Vertical diplopia 152
Vertigo 190–193
in audiovestibular disorders 190 193 193
central lesions causing 190 192
cervical 191–192
episodic 190
in Meniere's syndrome 190
recurrent vestibulopathy 190
in labyrinthitis 191
migrainous 192
in multiple sclerosis 194
in perilymphatic fistula 191
peripheral lesions causing 190 191–192
positioning 191
traumatic 191
vascular compromise causing 194
in vestibular neuronitis 191
vestibular schwannoma (acoustic neurinoma) causing 193 193
Very-low-calorie diets 1268–1269
Very-low-density lipoproteins 1240
in atherosclerosis and heart disease 1241 1241–1242
lowering levels of See Lipid-lowering therapy
Vesical pain 931
Vesicoureteral reflux, tubulointerstitial disease caused by 926 927
Vesicular dermatoses 92 108–113
Vesicular lung sounds 221
Vesiculobullous hand eczema/vesiculobullous dermatitis of palms and soles (pompholyx/dyshidrosis/dyshidrotic eczema) 111–112
Vestibular disorders 193–194 193
immobility in elderly and 60
nausea and vomiting caused by 81 539
neuronitis 191
schwannoma (acoustic neuroma) 193–194
vertigo in 190 193
Vestibulitis
nasal 197
vulvar 747 748
Vestibulopathy, recurrent 191
Veterans Administration Cooperative Study 1203
Vexol See Rimexolone
VFend See Voriconazole
VHL gene, testing for, in pheochromocytoma 1175
Viagra See Sildenafil
Vibrio 1428 1553
alginolyticus 1428
cholerae 1299 1300 1302 1427 1428
immunization against 1313 1428
diarrhea/food poisoning caused by 546 1299 1300 1302 1428
parahaemolyticus 1299 1302 1428
vulnificus 1428
Vicodin See Hydrocodone
Vidarabine 1353
Video-assisted thoracoscopic surgery (VATS), for solitary pulmonary nodule 266
Videoesophagography 564
Videx See Didanosine
Vigabatrin, adverse ocular effects of 178
VIN See Vulvar intraepithelial neoplasia
Vinblastine 1674
Vincent's infection 204
Vincristine 1674
neuropathy caused by 1683–1684
Raynaud's disease/phenomenon caused by 465
Vinorelbine 1665 1674
neuropathy caused by 1683–1684
Vioform See Iodoquinol
Violence 1081–1082
domestic 1081 1082
elder abuse and 17 51 54 54 1094
prevention of 16–17
prevention of 16–17
Vioxx See Rofecoxib
VIP See Vasoactive intestinal polypeptide
VIPomas 1178 1191 1692
Vira-A See Vidarabine
Viracept See Nelfinavir
Viral infections 1349–1391
adenovirus 1386–1387
arthritis and 858
cancer etiology and 1644
clinical diagnosis of 1349
drug therapy for 1350 1352–1353 1586–1588
exanthematous 1355–1356 1387–1389
gastroenteritis 545 1299 1389
herpesviruses 1350–1362
laboratory diagnosis of 1349–1350
neurotropic 1369–1376
pericarditis 407
respiratory 1381–1386
rhinitis (common cold) 194–195 1387
cough in 219
echinacea for 1712 1716
over-the-counter remedies for, in elderly 65–66
transfusion-related transmission of 534
vaccine-preventable 1362–1369
Viral load tests (HIV) 1330 1330
antiretroviral therapy initiation/monitoring and 1336 1339
laboratory reference range for 1739
Viramune See Nevirapine
Virchow's node 597
Virchow's triad 281 470
Viread See Tenofovir
Viridans streptococci 1402 1552
endocarditis caused by 1402 1415 1417–1418
Virilization 1170–1172
in persistent anovulation (polycystic ovary syndrome) 746 747 1170 1171
Viroptic See Trifluridine
Virtual colonoscopy
in adenomatous polyp identification 634
in colorectal cancer screening 16 643 1656
Viruses See also Viral infections
in cancer etiology 1644
laboratory identification of 1349–1350
Visceral aneurysms 450–451
Visceral artery insufficiency 459–460
Visceral hypersensitivity (heightened visceral nociception)
chest pain and 581
irritable bowel syndrome and 615
Visceral larva migrans (toxocariasis) 1534–1535
Visceral leishmaniasis (kala azar) 1480 1482–1484
dermal leishmaniasis after 1483
Viscerotropic disease, yellow fever vaccine-associated 1315
Viscocanalostomy, for glaucoma 161
Vision
blurred 150
double See Diplopia
Visken See Pindolol
Vistaril See Hydroxyzine
Visual acuity
assessment of 151
in optic neuritis 169
reduced See Visual impairment/loss
in retinal artery occlusion 166
in retinal vein occlusion 165
visual impairment/blindness and 150–151
in vitreous hemorrhage 164
Visual field defects/loss 150
in anterior ischemic optic neuropathy 169
assessment of 152
in glaucoma 160
in headache 32 975
intracranial mass lesions causing 1001
in optic neuritis 169
in papilledema 169
in retinal artery occlusion 166
in stroke 991 993
Visual field testing 152
Visual impairment/loss 150–151
in age-related macular degeneration 164 165
in amaurosis fugax 166
in anterior ischemic optic neuropathy 169
in botulism 1410
cataract causing 163
confusion/dementia and 57
in diabetes 167 1198 1198 1221
in elderly, screening for 51 52
episodic (amaurosis fugax) 166
in giant cell arteritis 846
in glaucoma 159 160 161
in headache 32 975
onchocerciasis causing 1527 1528
ophthalmologic referral for 153
in optic neuritis 169
in papilledema 169
in pseudotumor cerebri 1005
refractive errors causing 153–154
in retinal artery occlusion 166
in retinal detachment 163
in retinal vein occlusion 165
stroke causing 991 993
in toxoplasmosis 1499
in uveitis 162
in vitreous hemorrhage 164
Vital capacity (VC) 223
forced (FVC) 223
in asthma 227
in COPD 238
ratio of to forced expiratory volume in one second 222 223
in asthma 227
in COPD 238
Vital signs, in heart disease 314
Vitamin A (retinol) 1276
adverse ocular effects of 179
in cancer prevention 1276
dietary reference intakes (DRIs) for 1254
Vitamin B1 (thiamin) 1272–1273
for alcohol withdrawal 1086
for coma 1017 1608
P.1882
deficiency of 1272–1273
alcohol dependency/abuse and 1084 1103 1272
alcoholic ketoacidosis and 888
amnestic syndrome and 1092
mental status changes caused by 1103
neuropathy associated with 1025 1273
Wernicke's encephalopathy/Wernicke-Korsakoff syndrome caused by 1017 1084 1092 1103 1273
dietary reference intakes (DRIs) for 1254
vitamin B2 (riboflavin) 1273
dietary reference intakes (DRIs) for 1254
mental changes associated with deficiency of 1103
Vitamin B3 (niacin) 1273–1274
dietary reference intakes (DRIs) for 1254
for lipid modification/heart disease prevention 1249 1251 1273–1274
mental changes associated deficiency of 1103 1274
Vitamin B6 (pyridoxine) 1274–1275
dietary reference intakes (DRIs) for 1254
for gyromitrin mushroom poisoning 1630
for homocystinuria 1706
hyperhomocysteinemia associated with deficiency of 1707
for isoniazid overdose/toxicity 1274 1611 1626
mental changes associated with deficiency of 1103
Vitamin B12 (cobalamin) 487 1275
deficiency of 487–488 487
in bacterial overgrowth 487 605
fish tapeworm infection and 487 1509
in hyperhomocysteinemia 1707
mental changes and 1103
neuropathy associated with 487 1025
pernicious anemia and 487 585
short bowel syndrome/ileal resection and 487 605 606
subacute combined degeneration of spinal cord caused by 1016
dietary reference intakes (DRIs) for 1254
malabsorption of, in pancreatitis 698
proton pump inhibitors affecting 588
serum levels of
laboratory reference range (normal values) for 1743
in overt vitamin B12 deficiency state 488
in polycythemia 501
supplemental 488
for subacute combined degeneration of spinal cord 1017
Vitamin B12 absorption test (Schilling test)
in bacterial overgrowth 605
laboratory reference range (normal values) for 1743
Vitamin C (ascorbic acid) 1275–1276
dietary reference intakes (DRIs) for 1254
Vitamin D 1158–1159 1276
adverse ocular effects of 179
deficiency of/resistance to
bone pain and 1102
in hypocalcemia 877 878
in osteomalacia 1158 1159 1160–1161
in osteoporosis 1155
dietary/supplementary
bisphosphonate therapy and 1157
dietary reference intakes (DRIs) for 1254
hypercalcemia caused by 880 1152
for hyperparathyroidism 1154
for hypocalcemia/hypoparathyroidism/tetany 878 1148 1149 1149
for osteomalacia 1157 1160
for osteoporosis prevention/management 761 1157
hypercalciuria and 944 945
in hypophosphatemia 881
laboratory reference range for 1743
in phosphate metabolism 880
Vitamin D-dependent rickets 1159
Vitamin D-resistant (hypophosphatemic) rickets 874 1159
vitamin D2 (ergocalciferol/ergosterol) 1158
for hypoparathyroidism/tetany 1149 1149
for osteomalacia 1160–1161
vitamin D3 (cholecalciferol) 1158
Vitamin E 1277
in cancer prevention 1277 1650–1651
deficiency of 1016 1277
dietary reference intakes (DRIs) for 1254
toxicity of 1277
Vitamin K 529
for anticoagulant overdose 1619
in coagulation 529
deficiency and 529–530
liver disease and 528–529
dietary reference intakes (DRIs) for 1254
for esophageal varices 575
for hypoprothrombinemia, in cirrhosis 673
in pregnancy, for seizure disorders 780
Vitamins 1258 1272–1277
adverse ocular effects of 179
deficiency of 1272
in alcoholic liver disease/cirrhosis 664 669 670 1103
mental status changes caused by 1103
disorders of metabolism of 1272–1277
excess/toxicity of 1272
fat-soluble 1258
digestion of 601
prenatal 766–767
requirements for 1258
dietary reference intakes (DRIs) for 1254
in nutritional support 1282
water-soluble 1258
Vitiligo 143 143–144 1100
in Addison's disease 1165
tinea versicolor differentiated from 104
Vitrasert See Ganciclovir
Vitreous hemorrhage 164
Vitreous opacities, floaters caused by 151
Vittaforma corneae 1477
Vivactil See Protriptyline
Vivelle See Estradiol transdermal systems
Vivelle-Dot See Estradiol transdermal systems
VLDL See Very-low-density lipoproteins
VlsE, B burgdorferi, Lyme disease diagnosis and 1459
VMA See Vanillylmandelic acid
VO2 (maximal oxygen uptake), lung cancer surgery and 270
Vocal cord dysfunction syndrome 225
Vocal cords
cancer of 211–212 212
nodules of 210
laryngitis and 210
paralysis of 213
thyroid surgery and 213 1125 1140
Vogt-Koyanagi-Harada syndrome 162
Voice, abnormal, evaluation of 209
Voiding
dysfunctional, in prostatodynia 942
increased See Polyuria
irritative symptoms associated with 932
obstructive symptoms associated with 932
painful (dysuria) 33–34 932
Voltaren See Diclofenac
Volume depletion See also Dehydration
saline-responsive metabolic alkalosis and 891
Volume reduction surgery, for COPD 242–243
Volume replacement See also Fluid management/hydration
for shock 479
Volume status, hyperosmolality and 872
Volutrauma, mechanical ventilation and 308
Vomiting 520 539
in cholecystitis 686
in gastric outlet obstruction 538 539 594
induced
in bulimia nervosa 1271 1272
for poisoning/drug overdose 1611
Mallory-Weiss syndrome and 538 572
of pregnancy 538 767
Vomiting center 538
von Hippel-Lindau syndrome
pheochromocytoma in 1174 1175
renal cell carcinoma in 969
Von Willebrand disease 523–525 525
Von Willebrand factor 523 524
in Bernard-Soulier syndrome 523 525
von Willebrand factor-cleaving protease (ADAMTS13) deficiency
in hemolytic-uremic syndrome 522
in thrombotic thrombocytopenic purpura 521
Voriconazole 1549 1550 1585
for candidiasis 1537
for coccidioidomycosis 1540
cost of 1561 1563
therapy adjustments in renal or hepatic failure and 1559
Voyeurism 1052 1053
VPBs See Ventricular arrhythmias, premature beats
VSD See Ventricular septal defect
VT (tidal volume) 221 223
Vulvar carcinoma 739–740
Vulvar dystrophy 739
Vulvar intraepithelial neoplasia (VIN) 739
Vulvar vestibulitis 747 748
Vulvar warts 732 733
Vulvectomy 739
Vulvodynia 747 748
Vulvovaginal candidiasis 121 732 1536
in diabetes mellitus 1198 1198 1226
in HIV infection/AIDS 1329 1336 1347
Vulvovaginitis See Vaginitis
vWF See Von Willebrand factor
VZIG See Varicella zoster immune globulin
VZV See Varicella-zoster virus